MR
Mithun Roy
National Institute of Technology Agartala, National In, Indian Institute of Science Bangalore, University of North Bengal, University of Colorado Boulder
0000-0003-0045-6342
Employment
-
National Institute of Technology Agartala Associate Professor2024 - Present
-
National In Associate Professor2014 - 2024
-
University of Colorado Boulder Research Associate2013 - 2014
-
Ruprecht Karls Universität Heidelberg Research Associate2011 - 2012
-
Indian Institute of Science Research Associate2009 - 2011
Education
-
Indian Institute of Science Bangalore PhD2004 - 2009
-
University of North Bengal MSc2001 - 2003
-
University of North Bengal BSc1998 - 2001
Projects & Funding
Projects & funding information is unavailable.
Publications (59)
- Bio-reductive hetero-bimetallic Co(iii)–Pt(ii) complex for tumor-selective platinum release and cytotoxicity Save
- Red‐Light Activable Oxovanadium(IV)‐Gold Nanoparticles (VO@AuNPs) for Next‐Generation Photodynamic Therapy: Design, Photophysics, and Therapeutic Evaluation Save
- MnI(CO)3-Prussian blue nanohybrids (MnI(CO)3@PBNPs) as red light-activatable platforms for synergic photo-activated chemotherapy and photodynamic therapy Save
- Synthesis, Protein‐Binding Studies and Red Light‐Assisted Cytotoxicity of Iron(III)‐phenolato/Carboxylate Functionalized‐Graphene Oxide and Single‐Wall Carbon Nanotube Save
- A New Hetero‐Bimetallic [Fe(III)‐Mn(I)] Complex as a Dual Modality, Theranostic Tool for Photoactivated Anticancer Therapy Save
- A red light-activable hetero-bimetallic [Fe(iii)–Ru(ii)] complex as a dual-modality PDT tool for anticancer therapy Save
- Bio-reductive Co(iii)–doxorubicin complex for cancer cell-selective delivery of doxorubicin and potent anticancer activity Save
- Characterization of Second-Line Drug-resistance Mutations in Multidrug-resistant Mycobacterium tuberculosis Isolates of Andhra Pradesh, India Save
- Targeted Chemo‐Phototherapy in Red Light with Novel Doxorubicin and Iron(III) Complex‐Functionalized Gold Nanoconjugate (Dox‐Fe@FA‐AuNPs) Save
- Recent advances on the development of NO-releasing molecules (NORMs) for biomedical applications Save